Anti‐inflammatory activity of antifungal preparations

Background Although steroid/antifungal combination medications are used extensively, they are associated with potential disadvantages. Antifungal preparations possessing inherent anti‐inflammatory activity, leading to rapid symptomatic relief while providing mycologic cure, would be very useful.

[1]  Mostafa Mokhtar,et al.  NAFTIEINE VERSUS MICONAZOLE/HYDROCORTISONE IN INFLAMMATORY DERMATOPHYTE INFECTIONS , 1994, International journal of dermatology.

[2]  I. James,et al.  Does naftifine have anti‐inflammatory properties? A double‐blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin , 1993, The British journal of dermatology.

[3]  H. Jones.  Immune response and host resistance of humans to dermatophyte infection. , 1993, Journal of the American Academy of Dermatology.

[4]  J. Uitto,et al.  Direct interaction of antifungal azole-derivatives with calmodulin: a possible mechanism for their therapeutic activity. , 1993, The Journal of investigative dermatology.

[5]  E. Peets,et al.  Clotrimazole/Betamethasone Dipropionate — Lotrisone® — An Antifungal/Steroid Combination for Treatment of Cutaneous Dermatophyte Infections , 1992 .

[6]  L. Millikan,et al.  Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis. , 1992, Journal of the American Academy of Dermatology.

[7]  T. Hoehler,et al.  Ciclopirox olamine: a hydroxypyridone antifungal agent. , 1991, Clinics in dermatology.

[8]  F. Odds,et al.  The antiinflammatory effects of ketoconazole. A comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea-pigs. , 1991, Journal of the American Academy of Dermatology.

[9]  M. Plempel,et al.  Modulation of leukotriene metabolism from human polymorphonuclear granulocytes by bifonazole , 1991, Mycoses.

[10]  D. Steinhilber,et al.  Effects of novel antifungal azole derivatives on the 5-lipoxygenase and cyclooxygenase pathway. , 1990, Arzneimittel-Forschung.

[11]  R. Calderón,et al.  Immunoregulation of dermatophytosis. , 1989, Critical reviews in microbiology.

[12]  C. Savopoulos,et al.  Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses. , 1988, Clinical therapeutics.

[13]  M. Dahl.  Immunological resistance to dermatophyte infections. , 1987, Advances in dermatology.

[14]  F. De Clerck,et al.  Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. , 1986, Biochemical pharmacology.

[15]  M. Dahl,et al.  Polymorphonuclear leukocytes, complement, and Trichophyton rubrum. , 1986, The Journal of investigative dermatology.

[16]  H. Tronnier,et al.  Investigations into the Anti-inflammatory Effect of Bifonazole , 1986 .

[17]  J. Greenberg,et al.  Temporal correlation of lymphocyte blastogenesis, skin test responses and erythema during dermatophyte infections. , 1977, Clinical and experimental immunology.

[18]  R. Mertens,et al.  A double-blind study comparing Daktacort, miconazole and hydrocortisone in inflammatory skin infections. , 1976, Dermatologica.